SAB Biotherapeutics (SABS) Net Equity Issued and Repurchased (2020 - 2026)
SAB Biotherapeutics (SABS) recorded Net Equity Issued and Repurchased of $543,000 in Q2 2026, down 81.7% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
On a TTM basis, SAB Biotherapeutics' Net Equity Issued and Repurchased came in at $3.52 million as of Jun 30, 2026; for FY2024, it was $20,409, down 100.0% from FY2023.
- Annual Net Equity Issued and Repurchased has a four-year compound annual growth rate of -78.7% (FY2020 to FY2024).
- Across earlier years, Net Equity Issued and Repurchased came in at $59.65 million in FY2023 (+676.7%), $7.68 million in FY2022, $6,750 in FY2021 (-99.9%) and $9.9 million in FY2020.
- The Q2 2026 figure is the lowest quarterly Net Equity Issued and Repurchased since Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | SAB Biotherapeutics | 264.67 Mn | 264.67 Mn | - | 543,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 543,000.00 |
| Mar 31, 2026 | 2.98 Mn |
| Dec 31, 2024 | -3.00 |
| Mar 31, 2024 | 20,412.00 |
| Dec 31, 2023 | 59.65 Mn |
| Sep 30, 2023 | 2,430.00 |
| Mar 31, 2023 | 1,890.00 |
| Dec 31, 2022 | 7.60 Mn |
| Sep 30, 2022 | 1.00 |
| Jun 30, 2022 | 69,141.00 |
| Mar 31, 2022 | 7,830.00 |
| Dec 31, 2021 | -4.17 Mn |
| Mar 31, 2021 | 4.17 Mn |
| Dec 31, 2020 | 25,000.00 |
API Access
SAB Biotherapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();